Cargando…
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults
OBJECTIVE: Assessing safety and immunogenicity of an inactivated whole virus particle vaccine. DESIGN: Single-centre, double-blind, randomised, placebo-controlled, phase I (stage I: 18–50, stage II: 51–75 years), phase II (18–75 years) clinical trials. SETTING: 29 December 2020 to 22 April 2021. PAR...
Autores principales: | Mohraz, Minoo, Salehi, Mohammadreza, Tabarsi, Payam, Abbasi-Kangevari, Mohsen, Ghamari, Seyyed-Hadi, Ghasemi, Erfan, Amini Pouya, Maryam, Rezaei, Negar, Ahmadi, Naser, Heidari, Kazem, Malekpour, Mohammad-Reza, Nasiri, Mojtaba, Amirzargar, Ali Akbar, Saeedi Moghaddam, Sahar, Larijani, Bagher, Hosseini, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995575/ https://www.ncbi.nlm.nih.gov/pubmed/35396297 http://dx.doi.org/10.1136/bmjopen-2021-056872 |
Ejemplares similares
-
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
por: Mohraz, Minoo, et al.
Publicado: (2023) -
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
por: Salehi, Mohammadreza, et al.
Publicado: (2022) -
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies
por: Shafaati, Maryam, et al.
Publicado: (2023) -
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
Publicado: (2023) -
Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
por: Abbasi-Kangevari, Mohsen, et al.
Publicado: (2023)